Many doctors and scientists are cautiously optimistic about the South African Health Products Regulatory Authority's decision to allow what they call "compassionate and controlled" access to the Ivermectin drug to treat Covid-19. To unpack this, Anlie Hattingh speaks to Professor Colleen Aldous from the University of Kwazulu-Natal and Dr. Naseeba Kathrada. Courtesy #DStv403

свернуть